TKFC
protein-codingtriokinase and FMN cyclase
Gene summary
This gene is a member of the family of dihydroxyacetone kinases, which have a protein structure distinct from other kinases. The product of this gene phosphorylates dihydroxyacetone, and also catalyzes the formation of riboflavin 4',5'-phosphate (aka cyclin FMN) from FAD. Several alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jun 2017]
- DAK
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~20.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032927
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0032927
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0008922
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0003778
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Gastrointestinal; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TKFC variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015533.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 7 | 2 | 10 | ||
| missense | 2 | 107 | 5 | 114 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 4 | 4 | ||||
| Total | 0 | 2 | 114 | 12 | 2 | 130 |
Highest pathogenic variant AF is 0.00001364243
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_056348.2 | 17 | MANE Select | |
| Ensembl | ENSP00000378360.3 | 17 | MANE Select | |
| RefSeq | NP_001338905.1 | 17 | Standard | |
| RefSeq | NP_001338906.1 | 17 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Fructose and mannose metabolism - Homo sapiens (human)
- Glycerolipid metabolism - Homo sapiens (human)
- RIG-I-like receptor signaling pathway - Homo sapiens (human)
- RIG-I-like Receptor Signaling
- Fructose metabolism
Biological Process
- glycerol catabolic process
- negative regulation of MDA-5 signaling pathway
- cellular carbohydrate metabolic process
- innate immune response
- regulation of innate immune response
Molecular Function
- glycerone kinase activity
- protein binding
- ATP binding
- FAD-AMP lyase (cyclizing) activity
- metal ion binding
Cellular Component
- nucleus
- cytosol
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000394900
- Coding exons
- 17
- Length
- 20086
- Individuals with no LoFs
- 125579
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 169
- Defined
- 125748
- p
- 0.000672
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.395 | 352 | 373 | 0.943 | 0.0000239 | 3617 |
| Missense (PolyPhen) | 144 | 148.42 | 0.97022 | 1454 | ||
| Synonymous | 0.610 | 151 | 161 | 0.939 | 0.0000108 | 1288 |
| Loss of Function | 1.04 | 21 | 26.8 | 0.784 | 0.00000114 | 318 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0026 | 0.0026 | notable |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.0025 | 0.0025 | notable |
| Finnish | 0.000048 | 0.000046 | rare |
| European (Non-Finnish) | 0.00037 | 0.00032 | rare |
| South Asian | 0.0012 | 0.0011 | notable |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes both the phosphorylation of dihydroxyacetone and of glyceraldehyde, and the splitting of ribonucleoside diphosphate-X compounds among which FAD is the best substrate. Represses IFIH1-mediated cellular antiviral response (PubMed:17600090). {ECO:0000250|UniProtKB:F1RKQ4, ECO:0000250|UniProtKB:Q4KLZ6, ECO:0000269|PubMed:16289032, ECO:0000269|PubMed:17600090, ECO:0000269|PubMed:4688871}.;
Recessive Scores
- pRec
- 0.298
Intolerance Scores
- RVIS EVS
- -0.48
- RVIS percentile EVS
- 22.75
Essentials
- Essential (gene trap)
- N